UK Markets open in 6 hrs 49 mins

Novacyt S.A. (NCYT.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
110.00-0.50 (-0.45%)
At close: 04:35PM BST
Full screen
Previous close110.50
Open108.75
Bid108.50 x 0
Ask109.15 x 0
Day's range108.61 - 112.10
52-week range1.32 - 497.30
Volume40,073
Avg. volume226,441
Market cap78.212M
Beta (5Y monthly)-2.71
PE ratio (TTM)0.92
EPS (TTM)119.80
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Launch of Novacyt’s first fully lyophilised PROmate® assays

    PARIS & CAMBERLEY, England, August 04, 2022--Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT) ("Novacyt", the "Company" or the "Group"), an international specialist in clinical diagnostics, announces the launch of the Company’s first fully lyophilised (freeze-dried), direct-to-PCR assays. This new class of PROmate® assay enables shipping and transportation at ambient temperatures to remote regions or in areas without a centralised cold storage supply chain, providing an extended glob

  • Business Wire

    Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Launch of Research-Use-Only Adenovirus F41 Assay

    PARIS & CAMBERLEY, England, July 28, 2022--Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the launch of a research-use-only (RUO) polymerase chain reaction (PCR) assay for the detection of adenovirus F41, in response to recent cases of acute hepatitis in children. This launch expands Novacyt’s genesig® real-time PCR diagnostic product portfolio and is in line with the Company’s strategy to maintain its position as a gl

  • Business Wire

    Novacyt S.A. ("Novacyt", the "Company" or the "Group"): Approval of exsig™ COVID-19 Direct Test in the UK Under CTDA Legislation

    PARIS & CAMBERLEY, England, July 15, 2022--Regulatory News: Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s exsig™ COVID-19 Direct Real-Time PCR test has been approved in the UK under the UK Health Security Agency's Medical Devices (Coronavirus Test Device Approvals) (Amendment) Regulations 2021 ("CTDA").